• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者的小肝结节(≤2厘米):超声造影特征分析

Small hepatic nodules (< or =2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography.

作者信息

Wang Jing-Houng, Lu Sheng-Nan, Hung Chao-Hung, Chen Tai-Yi, Chen Chien-Hung, Changchien Chi-Sin, Lee Chuan-Mo

机构信息

Division of Hepatogastroenterology, Department of Internal Medicine and Radiology, Kaohsiung Chang Gung Memorial Hospital, Koahsiung, Taiwan.

出版信息

Liver Int. 2006 Oct;26(8):928-34. doi: 10.1111/j.1478-3231.2006.01318.x.

DOI:10.1111/j.1478-3231.2006.01318.x
PMID:16953832
Abstract

AIM

We evaluated the efficacy of contrast-enhanced ultrasonography (CEUS) for the characterization of small hepatic nodules (< or =2 cm) in cirrhosis patients.

PATIENTS AND METHODS

Thirty cirrhosis patients with 30 hepatic nodules (1-2 cm) were enrolled in this study. Eighteen hepatic nodules were hepatocellular carcinomas (HCC) and 12 were benign lesions. CEUS was performed using microbubble contrast (Levovist). With surrounding hepatic parenchyma as a reference, two characteristics of hepatic nodules, including arterial phase enhancement (AE) and the absence of delayed phase enhancement (ADE), were evaluated as criteria for the diagnosis of HCC. A radiologist independently reviewed the dynamic computed tomographies (CT) of 26 hepatic nodules.

RESULTS

CEUS showed AE in 15 nodules (13 HCC and two benign) and ADE in 17 lesions (14 HCC and three benign). For HCC, the coincidental AE of both CEUS and dynamic CT was 40%. Using both AE and ADE for HCC diagnosis, the sensitivity, specificity, accuracy, positive predictive value and negative predictive values were 55.6%, 91.7%, 70%, 90.9% and 57.9%, respectively. When using either AE or ADE for HCC diagnosis, the same parameters were 94.4%, 66.7%, 83.3%, 81% and 88.9%, respectively. One benign hepatic nodule with both AE and ADE was diagnosed as HCC 29 months after the CEUS study.

CONCLUSIONS

A combination of characteristics of AE and ADE as determined by CEUS was highly specific for small HCCs in cirrhosis patients. Concurrent delayed phase imaging is useful in the diagnosis of small hypovascular HCCs.

摘要

目的

我们评估了超声造影(CEUS)对肝硬化患者小肝结节(≤2 cm)特征的评估效能。

患者与方法

本研究纳入了30例肝硬化患者的30个肝结节(1 - 2 cm)。其中18个肝结节为肝细胞癌(HCC),12个为良性病变。使用微泡造影剂(声诺维)进行CEUS检查。以周围肝实质作为参照,将肝结节的两个特征,即动脉期增强(AE)和延迟期无增强(ADE),作为诊断HCC的标准。一名放射科医生独立回顾了26个肝结节的动态计算机断层扫描(CT)图像。

结果

CEUS显示15个结节有AE(13个HCC和2个良性结节),17个病变有ADE(14个HCC和3个良性结节)。对于HCC,CEUS和动态CT的AE符合率为40%。联合使用AE和ADE诊断HCC时,敏感性、特异性、准确性、阳性预测值和阴性预测值分别为55.6%、91.7%、70%、90.9%和57.9%。当单独使用AE或ADE诊断HCC时,相同参数分别为94.4%、66.7%、83.3%、81%和88.9%。一个同时具有AE和ADE的良性肝结节在CEUS检查后29个月被诊断为HCC。

结论

CEUS所确定的AE和ADE特征联合应用对肝硬化患者的小HCC具有高度特异性。同时进行延迟期成像对小乏血供HCC的诊断有用。

相似文献

1
Small hepatic nodules (< or =2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography.肝硬化患者的小肝结节(≤2厘米):超声造影特征分析
Liver Int. 2006 Oct;26(8):928-34. doi: 10.1111/j.1478-3231.2006.01318.x.
2
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?肝硬化患者初发和复发性结节的超声造影特征:应采用哪些血管标准?
Ultraschall Med. 2013 Jun;34(3):280-7. doi: 10.1055/s-0033-1335024. Epub 2013 Apr 24.
3
Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.在进行对比增强超声检查时,如果结节<2cm 没有动脉性高血管化,不应将其作为诊断性检查的优先事项。
J Hepatol. 2015 Jan;62(1):150-5. doi: 10.1016/j.jhep.2014.08.028. Epub 2014 Aug 27.
4
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.肝硬化中直径20毫米及以下肝脏结节的诊断:肝细胞癌无创诊断标准的前瞻性验证
Hepatology. 2008 Jan;47(1):97-104. doi: 10.1002/hep.21966.
5
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.根据美国肝病研究学会(AASLD)/欧洲肝脏研究学会(EASL)修订标准,直径≤2cm的肝细胞癌结节的诊断增强模式证据。
Abdom Imaging. 2013 Dec;38(6):1245-53. doi: 10.1007/s00261-013-0031-7.
6
Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.肝硬化肝癌发生的超声造影研究。
Chin Med J (Engl). 2012 Sep;125(17):3104-9.
7
Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.肝硬化小结节(1-2 厘米):超声造影的特征。
Eur J Radiol. 2009 Dec;72(3):418-24. doi: 10.1016/j.ejrad.2008.08.011. Epub 2008 Oct 1.
8
Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.对比增强多普勒超声在肝硬化患者肝细胞癌及癌前病变诊断中的应用
Hepatology. 2001 Dec;34(6):1109-12. doi: 10.1053/jhep.2001.29373.
9
Contrast-enhanced US of hepatocellular carcinoma.
Radiol Med. 2004 Apr;107(4):293-303.
10
Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.超声造影用于肝细胞癌的特征性诊断
Med Ultrason. 2011 Jun;13(2):108-13.

引用本文的文献

1
Using multimodal ultrasound technology to improve the success rate of liver tumor puncture for lesions with poor visibility on conventional ultrasound imaging.使用多模态超声技术提高常规超声成像下可见性差的肝脏肿瘤穿刺成功率。
Quant Imaging Med Surg. 2025 Jan 2;15(1):801-812. doi: 10.21037/qims-24-1392. Epub 2024 Dec 30.
2
High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.高帧率对比增强超声(HIFR-CEUS)在肝硬化患者小肝病变中的特征描述。
J Ultrasound. 2023 Mar;26(1):71-79. doi: 10.1007/s40477-022-00724-w. Epub 2022 Oct 13.
3
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
4
Characteristics of hepatic solitary necrotic nodules on contrast-enhanced ultrasonography.超声造影检查对肝脏单发坏死性结节特征的分析。
BMC Gastroenterol. 2021 Jan 25;21(1):35. doi: 10.1186/s12876-021-01608-9.
5
Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis.超声造影在肝脏局灶性病变中的应用特征:一项综合荟萃分析。
Eur Radiol. 2018 May;28(5):2077-2088. doi: 10.1007/s00330-017-5152-x. Epub 2017 Nov 30.
6
Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.超声造影在肝细胞癌中的诊断价值:一项基于1998年至2016年证据的Meta分析
Oncotarget. 2017 Aug 7;8(43):75418-75426. doi: 10.18632/oncotarget.20049. eCollection 2017 Sep 26.
7
Assessing diagnostic value of contrast-enhanced ultrasound and contrast-enhanced computed tomography in detecting small hepatocellular carcinoma: A meta-analysis.评估超声造影和对比增强计算机断层扫描在检测小肝细胞癌中的诊断价值:一项荟萃分析。
Medicine (Baltimore). 2017 Jul;96(30):e7555. doi: 10.1097/MD.0000000000007555.
8
Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis.超声造影诊断小肝细胞癌的Meta分析及Meta回归分析
Tumour Biol. 2013 Dec;34(6):3667-74. doi: 10.1007/s13277-013-0948-z. Epub 2013 Jun 27.
9
Evaluation of contrast-enhanced ultrasonography using perfluorobutane (Sonazoid(®)) in patients with small hepatocellular carcinoma: comparison with dynamic computed tomography.使用全氟丁烷(声诺维(®))对小肝细胞癌患者进行超声造影评估:与动态计算机断层扫描的比较
Oncol Lett. 2010 May;1(3):485-488. doi: 10.3892/ol_00000085. Epub 2010 May 1.
10
Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid.使用Sonazoid增强超声检查后肝细胞癌治疗中的临床转化
Oncol Lett. 2010 Jan;1(1):57-61. doi: 10.3892/ol_00000010. Epub 2010 Jan 1.